News | December 28, 2011

First Clinical Uses Announced of Magellan Robotic System for Peripheral Vascular Disease

December 28, 2011 – Hansen Medical, a developer of robotic technology for accurate 3-D control of catheter movement, announced the world's first uses of the Magellan robotic system in the treatment of peripheral vascular disease (PVD). The clinical procedures were performed by Professor Nick Cheshire, M.D., and the medical team at St. Mary's Hospital, part of the Imperial College Healthcare in London, pioneers in the use of flexible robotics in vascular interventions.

The Magellan robotic system is a new robotic approach in the treatment of vascular disease, and it has the potential to transform the way endovascular treatments are performed for patients with PVD. The system allows precise catheter navigation of peripheral vessels with a proprietary technology that enables independent distal tip control of a catheter and a sheath, as well as robotic manipulation of a standard guidewire from a centralized, remote workstation. The system was designed to allow precise and predictable catheter navigation of peripheral vessels while reducing procedure time, lessening radiation exposure, lowering procedural fatigue and enabling new procedures.

"Hansen Medical's new Magellan robotic system opens up the possibility for physicians to offer less invasive endovascular options to a broader group of patients suffering from complex disease," said Professor Nick Cheshire, head of circulation sciences at Imperial College Healthcare. "Imperial College has been pioneering the use of flexible robotics in vascular interventions, and the Magellan robotic system now gives us access to the latest robotic catheter technology that is specifically designed for peripheral vascular interventions."

Hansen Medical's Magellan robotic system is based upon the leading flexible robotic technology incorporated in the Sensei-X robotic catheter system currently sold in the U.S. and Europe, which has been used in nearly 7,000 patients with cardiac arrhythmia, but includes a number of key enhancements. In particular, the Magellan Robotic System:

  • Allows for complete, individual robotic control of the distal tips of both the outer sheath and the inner leader catheter, as well as robotic manipulation of standard guidewires.
  • Is designed to allow for sufficient extension inside the body to better access hard to reach peripheral anatomy.
  • Preserves the open architecture featured in the Sensei system to allow for the subsequent use with most 6F therapeutic devices on the market today.
  • Employs a catheter that is expected to be available in multiple lengths and has a low profile with significant flexibility to be compatible with most 6F treatment catheters currently used today.

Last year, Hansen announced the completion of its first-in-man study in Europe during which 20 endovascular procedures were successfully performed with an earlier version of the Magellan robotic system, demonstrating its potential to allow physicians to effectively treat peripheral vascular disease, while lessening radiation exposure.

In Europe, the Magellan robotic system and NorthStar robotic catheter are CE marked. In the United States, the Magellan robotic system requires U.S. Food & Drug Administration (FDA) clearance, and a 510(k) application is currently pending.

For more information: www.hansenmedical.com

 

Related Content

Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Philips is partnering with HeartFlow to co-develop new FFR-CT and FFR-angiography imaging technologies.
News | FFR Technologies| August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc.
Sponsored Content | Videos | Angiography| June 22, 2017
Shimadzu Medical Systems highlighted new features of its Trinias Interventional X-ray line at the America College of
3d printing can aid procedural navigation in transcatheter tricuspid procedures
News | 3-D Printing| June 15, 2017
June 15, 2017 – Structural heart interventions are increasingly applied in patients with severe tricuspid regurgitati
Sponsored Content | Videos | Cardiovascular Ultrasound| June 15, 2017
Madhav Swaminathan, M.D., FASC, FAHA, clinical director of cardiothoracic anesthesiology, at Duke Univer
Large Multicenter Study Shows High Success Rate for Robotic PCI Procedures, SCAI, Corindus CorPath 200
News | Robotic Systems| May 16, 2017
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical...
Robotic-Assisted PCI With CorPath GRX Broadcast Live at TCT Asia-Pacific Summit
News | Robotic Systems| May 01, 2017
Corindus Vascular Robotics Inc. announced that Fu Wai Hospital in China performed and broadcast live a percutaneous...
Clinical Study Validates Efficiencies of Stereotaxis Niobe ES System Over Niobe II System
News | Robotic Systems| April 24, 2017
A recent study conducted at Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France validated the advantages of...
Overlay Init